Minerva Neurosciences, Inc. — Director's Dealing 2017

Jan 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-01-11

Reporting Person: Reilly Joseph H. (SVP & Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-11	Common Stock	M	1600	$4.71	Acquired	9933	Direct
2017-01-11	Common Stock	S	1600	$12.03	Disposed	8333	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-11	Stock Option (Right to Buy)	$4.71	M	1600	Disposed	2025-12-03	Common Stock (1600)	Direct

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016.

F2: This option shall vest as follows: 25% vested December 14, 2016 and then in quarterly installments over 3 years thereafter.